CGEN – compugen ltd. - ordinary shares (US:NASDAQ)

News

Compugen Ltd. (NASDAQ: CGEN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
Compugen to Participate in Two Upcoming Investor Conferences
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com